ABC Program in Patients With Metabolic Syndrome

Weight Reduction in Patients With Metabolic Syndrome Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01417871
• Other study ID #: abcmetsyn1
• Status: Completed
• Phase: N/A
• First received: August 15, 2011
• Last updated: August 15, 2011
• Start date: February 2010
• Est. completion date: August 2011

Study information

• Verified date: February 2010
• Source: University of Magdeburg
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Federal Institute for Drugs and Medical Devices
• Study type: Observational

Clinical Trial Summary

Aims: We evaluate the efficacy of the "Active Body Control (ABC) Program" for weight reduction in patients with metabolic syndrome.

Methods: The ABC program combines telemonitoring of the physical activity with a low-calorie diet also preferring carbohydrates with low glycemic indexes. In this 12-month, randomized, clinical trial 60 patients will be treated according to the ABC program and 60 control patients will receive standard therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 140
• Est. completion date: August 2011
• Est. primary completion date: August 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 25 Years to 75 Years

Eligibility

Inclusion Criteria:

• metabolic syndrome

Exclusion Criteria:

• tumor cachexia

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Metabolic Syndrome X
• Weight Loss
• Weight Reduction in Patients With Metabolic Syndrome

Locations

Country	Name	City	State
Germany	University Magdeburg	Magdeburg

Sponsors (1)

Lead Sponsor	Collaborator
University of Magdeburg

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	weight reduction		12 month	Yes
Secondary	incidence of metabolic syndrome		12 month	Yes